Remicade Overdose, Contraindications and Information - Infliximab

Remicade Overdose, Contraindications and Information - Infliximab

OVERDOSE

Single doses up to 20 mg/kg have been administered without any direct toxic effect. In case of overdosage, it is recommended that the patient be monitored for any signs or symptoms of adverse reactions or effects and appropriate symptomatic treatment instituted immediately.

REMICADE is contraindicated in patients with moderate or severe (NYHA Class III/IV) congestive heart failure (see WARNINGS, Congestive Heart Failure).

REMICADE should not be administered to patients with known hypersensitivity to any murine proteins or other component of the product.